Journey Through the Growth Economy

Naveen Jain and Michael Graham discuss personalized health, microbiome science, and the shift from DNA to RNA testing.

49 min Listen to the original
Personalized MedicineMicrobiomeLongevityViomeRNA TestingCancer DetectionNutritionHealth Tech

Summary

Naveen Jain, founder of Viome, and Michael Graham discuss the limitations of the current medical system and the potential of personalized longevity. Jain explains his motivation stemming from his father's pancreatic cancer diagnosis and outlines Viome's shift from static DNA testing to dynamic RNA analysis to detect early disease. He highlights the company's large biological database and claims regarding early cancer detection sensitivity. Graham expands on microbiome-driven product development, arguing against universal diets and supplements due to individual biological variations. He outlines a strategy to scale personalized health through segmentation and identifies five pillars of longevity: nutrition, stress, exercise, sleep, and purpose.

Episode sections

  1. 0:00 – 2:04

    Introduction and Guest Background

    Michael Graham introduces Naveen Jain, founder of Viome, highlighting his history with InfoSpace and Viome's role in personalized wellness.

  2. 2:04 – 7:57

    Motivation and the Medical Industrial Complex

    Jain explains his motivation stems from his father's pancreatic cancer diagnosis, criticizing the US medical system for incentivizing sickness over prevention and early detection.

  3. 7:57 – 14:27

    Entrepreneurial Framework: Why, Why Now, Why Me

    Jain outlines his three-question framework for starting ventures: solving a problem for billions, leveraging exponential technology trends, and challenging industry fundamentals.

  4. 14:27 – 25:21

    Viome's Technology and Data Scale

    Jain details Viome's shift from DNA to RNA testing to measure dynamic biological changes, citing a database of 1.5 million tests and 10 quadrillion data points.

  5. 25:21 – 28:01

    Personalized Nutrition and Supplements

    The speaker describes Viome's 'full-body intelligence' test providing personalized food and supplement recommendations, including monthly custom-formulated supplements and probiotics.

  6. 28:01 – 30:37

    Clinical Outcomes and GLP-1 Support

    Jain cites clinical trial results showing improvements in A1C, IBS, anxiety, and bone loss, and introduces products designed to mitigate side effects of GLP-1 medications.

  7. 30:37 – 32:58

    Early Cancer Detection and Competitive Advantage

    Jain highlights Viome's stage one pancreatic cancer test with high sensitivity/specificity, contrasting it with competitors like Grail who use cell-free DNA and miss early-stage cancers.

  8. 32:58 – 35:28

    Pricing Strategy and Recent Acquisitions

    Jain explains Viome's low pricing strategy ($3.99 for RNA tests) to drive adoption and mentions the acquisition of Solaria Bio for its edible microbiome strains.

  9. 35:28 – 37:53

    Microbiome-Driven Product Development

    Michael Graham describes a consortium of three bacteria and a fungi that showed 85% improvement in women with osteopenia and 75% in those with high BMI. He explains how their database identifies specific gut microbiome changes for conditions like joint pain or hair loss to develop targeted probiotic and prebiotic products every three to nine months.

  10. 37:53 – 40:16

    Critique of Universal Diets and Supplements

    Graham asserts there is no universal healthy food, citing that 43% of people are harmed by broccoli due to high sulfide production. He warns that supplements like NAD, NMN, and NR can increase cancer progression and that Akkermansia is linked to multiple sclerosis and Parkinson's disease.

  11. 40:16 – 42:21

    Scaling Personalized Health via Segmentation

    Graham outlines a strategy to bring personalized health to the masses by moving from individual 'N of one' testing to segment-based and condition-based products. He notes that as sequencing and AI costs plummet, tests could drop from $995 to $399 for three tests, with future potential for $10-$30 pricing.

  12. 42:21 – 48:42

    Five Pillars of Longevity

    Graham identifies five fundamental factors for healthier aging: nutrition (personalized fuel), stress management (reducing cortisol impact on the microbiome), exercise (walking and strength training), sleep quality (REM and deep sleep), and purpose/community (linked to living 8-10 years longer).

Claims worth verifying

Naveen Jain's father was diagnosed with stage four pancreatic cancer and given only a few months to live.

Michael Graham ·2:24

How to verify: Biographical records of Naveen Jain or Viome corporate history pages detailing founder motivation. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

The cost of human sequencing has dropped to $4.73 for Jain's personal test.

Michael Graham ·15:53

How to verify: Viome pricing page or financial reports disclosing R&D/sequencing costs. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

The cost of processing biological data has dropped from $50 per sample to $0.90.

Michael Graham ·16:22

How to verify: Viome technical whitepapers or industry reports on bioinformatics processing costs. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

The human microbiome produces between 2 million to 20 million genes, compared to 22,000 human protein-coding genes.

Michael Graham ·20:00

How to verify: Scientific literature on the Human Microbiome Project or genomic databases (e.g., NCBI). For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Viome has conducted 1.5 million tests and collected 10 quadrillion biological data points.

Michael Graham ·24:27

How to verify: Viome press releases, investor presentations, or company website statistics. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Viome's stage one pancreatic cancer test has 86% sensitivity and 90% specificity.

Michael Graham ·30:55

How to verify: Peer-reviewed clinical trial publications or FDA submission documents for Viome's diagnostic tests. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Grail's stage one cancer sensitivity is 13.7%.

Michael Graham ·31:15

How to verify: Grail (now part of Illumina) clinical trial results published in medical journals or investor presentations. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Viome's stage one pancreatic cancer test has a 99.9% negative predictive value.

Unidentified speaker (speaker_1) ·31:44

How to verify: Clinical validation studies or regulatory filings for Viome's pancreatic cancer diagnostic. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Viome's RNA tests retail for $3.99 on their website.

Michael Graham ·32:58

How to verify: Viome.com product page pricing at the time of the transcript. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

Exact Sciences has a 48% area under the curve for colon polyp detection.

Michael Graham ·33:38

How to verify: Exact Sciences clinical trial data or published studies on their stool-based DNA test accuracy. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

A consortium of three bacteria and a fungi showed 85% improvement in women with osteopenia and 75% improvement in women with high BMI.

Michael Graham ·35:54

How to verify: Check the company's clinical trial data, press releases, or published research papers detailing these specific efficacy percentages for osteopenia and BMI-related outcomes. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Primary source

43% of people are harmed by eating broccoli due to high sulfide production.

Michael Graham ·37:53

How to verify: Search for peer-reviewed studies or clinical data from the company supporting the claim that 43% of the population has high sulfide production and is negatively affected by broccoli. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Akkermansia is directly causative of multiple sclerosis and Parkinson's disease.

Michael Graham ·39:03

How to verify: Locate the specific journal article published around October 2026 that links Akkermansia abundance to these neurological conditions. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

The company's stool test cost dropped from $995 to $399 for three tests.

Michael Graham ·41:15

How to verify: Check the company's official website product pricing or recent investor deck slides showing historical and current pricing. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Michael Graham is 67 years old chronologically and has a biological age of 33.

Unidentified speaker (UNKNOWN) ·44:15

How to verify: Verify chronological age via public biographies or LinkedIn; verify biological age via third-party health assessments or company-provided biomarker dashboards. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Michael Graham's P-tau levels are below the level of detection.

Michael Graham ·45:12

How to verify: Request the specific lab results for P-tau testing from the company or a third-party diagnostic provider. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

People who live a life of purpose tend to live 8 to 10 years longer than those without purpose.

Michael Graham ·46:20

How to verify: Search for longitudinal studies in gerontology or psychology journals (e.g., Harvard Study of Adult Development) that quantify the lifespan impact of purpose and community. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Deep sleep moves toxins out via the lymphatic system, and REM sleep consolidates memory.

Michael Graham ·45:39

How to verify: Review neuroscience textbooks or peer-reviewed articles on sleep physiology regarding glymphatic system function during deep sleep and memory consolidation during REM sleep. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Blue Zone communities share close community ties as a common factor.

Michael Graham ·46:20

How to verify: Check published research on Blue Zones (e.g., by Dan Buettner) regarding social connectivity and longevity factors. For recent events, verify 2026-08-12 through 2026-11-12. Use another period only when the speaker explicitly names it.

Do your own research

  • Verify Viome's RNA testing methodology and compare it to standard DNA sequencing protocols via clinical white papers.
  • Check Grail's publicly reported sensitivity/specificity metrics for early-stage cancer detection to validate Jain's comparative claims.
  • Review peer-reviewed literature on the link between NAD/NMN/NR supplements and cancer progression to assess Graham's warning.
  • Search for the specific October 2026 journal article linking Akkermansia abundance to Parkinson's and multiple sclerosis cited by Graham.
  • Examine Viome's financial filings for details on the Solaria Bio acquisition and its integration into the microbiome product line.
  • Compare current industry costs for next-generation sequencing (NGS) against Graham's prediction of $10-$30 test pricing.
  • Look for independent clinical trial data supporting the efficacy of Viome's GLP-1 side effect mitigation products.
  • Verify the source of the '1.5 million tests' and '10 quadrillion data points' claims in Viome's investor presentations or press releases.
Full transcriptexpand
0:00
Michael Graham: Come along on our journey through the growth economy. I'm your host, Michael Graham, Director of Research at Canacord Genuity.
0:15
Michael Graham: Hello, listeners, and welcome back to the Longevity series. We're really excited to have Susan Anderson, managing director and senior consumer analyst covering health, wellness, and beauty here at the firm.
0:27
Michael Graham: Susan, this is the second episode in your longevity series, and you had an exciting uh guest, Naveen Jane, the founder of Viome. Uh, Viome is a pioneer in personalized wellness, and Naveen is a colorful and well-known entrepreneur going all the way back to the internet days when he founded InfoSpace.
0:47
Michael Graham: Tell us what you learned during the podcast.
0:50
Unidentified speaker (speaker_1): Thanks, Mike. Yeah, so longevity is rapidly moving into the mainstream, fueled by advances in science, changing consumer behaviors, and really just growing interest in living not just longer, but healthier lifestyles. And VIOM is really at the forefront of allowing consumers to do just that. And I'm thrilled to have the next uh
1:10
Unidentified speaker (speaker_1): speaker in our series, now not being James, as you mentioned, founder and CEO of. Biome.
1:16
Unidentified speaker (UNKNOWN): All
1:16
Michael Graham: right, let's jump right into it. Thank you, Susan.
1:19
Unidentified speaker (speaker_2): There is no such thing as
1:21
Michael Graham: universal healthy food because even spinach or broccoli can harm people. The only rule here is anytime you hear everyone should take something, unless your name is everyone, just don't take
1:35
Unidentified speaker (UNKNOWN): it.
1:35
Michael Graham: What is really happening is your body is constantly.
1:39
Michael Graham: sending us signals. It keeps whispering and we keep ignoring until it hits us.
1:47
Unidentified speaker (speaker_2): Naveen, thanks so much
1:48
Unidentified speaker (speaker_1): for joining us today. Um, before we dive into Viome and the broad broader longevity opportunity, why don't we start with you? Tell our listeners a little bit about yourself and your journey and what ultimately brought you into health. and longevity.
2:04
Michael Graham: Well, first of all, Susan, what a pleasure and honor to be with you. I have always enjoyed our discussions and I love reading your research notes because you're one of the most thoughtful and insightful analysts. So thank you for first of all having this podcast and thank you for uh bringing me on your podcast. Um, you know, I think you know,
2:24
Michael Graham: for me, the health and wellness journey. started with adversity, uh, which is always most companies always end up, you know, sometime, you know, adversity brings the best in us. In this particular case, um my dad was diagnosed with a stage four pancreatic cancer. And I didn't even
2:44
Michael Graham: know he was sick, let alone a stage four cancer. And unfortunately, he was only given a few months to. live, and that's all we got out of him. But it really got me thinking that how is it that in this 21st century we don't have the test for early detection
3:04
Michael Graham: for pancreatic cancer? But really, what got me thinking was that as uh I have watched him um you know grow older,
3:14
Unidentified speaker (UNKNOWN): I
3:15
Michael Graham: had just taken it for granted that of course he has diabetes, he's got to be taking his metformin, of course he's got a high blood pressure, he's getting old, of course he's got uh uh you
3:24
Unidentified speaker (UNKNOWN): know
3:24
Michael Graham: high cholesterol, he's getting old, of course he's got all these diseases, he's just getting old, right? And then I started to think about it, that there's you know, why is it that we as a human body, why does it develop these diseases? And does it really have to? And coming from a tech background, to me, it seemed like that if we were to really
3:44
Michael Graham: think about this problem from the biological data perspective and use AI, we should be able to understand why people develop these diseases. And and think to me, I always uh start to think, what if? What if we can act actually understand
4:04
Michael Graham: what changes in the human biology at the onset of these diseases, during the progression of these diseases, we should be able to diagnose them early, prevent them from happening, and God forbid, use food as a medicine to be able to reverse them. And that was my whole thesis: was that we got to
4:24
Michael Graham: be able to measure dynamically. what is changing in the human biology. Now, the fortunate part of the chronic diseases that I mentioned, whether it is diabetes or heart disease or Alzheimer's or Parkinson, so pick a name you want, cancer or any disease, they don't happen
4:44
Michael Graham: overnight. This is not like COVID or infectious disease. You come home and say, honey, I was out with a boy. the boys last night. I think I might have caught diabetes today. Right? You don't catch diabetes. You don't catch heart disease. It takes 8, 10, 15 years during the time these diseases are progressing
5:04
Michael Graham: slowly, slowly. And one day you wake up and you have a disease. And but it is not that. What is really happening is your body is constantly. sending us signals. It keeps whispering, here Susan, you know, this is really not working well. And it keeps sending
5:24
Michael Graham: these whisper and the signals, and we keep ignoring until it hits us hits us by you know with two by four and say, Oh my god, I can't believe I have diabetes, right?
5:36
Michael Graham: It's such a bad luck. And point is it's not. Before you have diabetes, you have fasting insulin starts to go up. And then your fasting glucose starts to grow up. And then your A1C starts to go up. And you go to your doctor, and your doctor says, Susan, you don't need to worry about it. You're
5:56
Michael Graham: only pre-diabetic right now. Wait until your you're diabetic. I cannot prescribe you any medicine right now because you're not even diabetic yet. And you're saying, I don't want to be diabetic. Or you say, Well, there's nothing I can do. Because,
6:11
Michael Graham: and my point is, our whole medical industrial complex, uh, Susan, it is especially in the United States, is so bad.
6:22
Unidentified speaker (UNKNOWN): Yeah,
6:22
Michael Graham: this is the only industry in the world where. you wake up every day and you hope that your customer is not happy. Think about that.
6:36
Michael Graham: The day your customer becomes happy and healthy, you stop making money.
6:40
Unidentified speaker (UNKNOWN): You become
6:41
Michael Graham: unhappy. You become unhappy, right? So our point is you only make money when your customer is unhealthy, sick, and unhappy, right? And everyone in the medical industry or complex makes money from that. And the person who does not want to be sick and unhappy and unhealthy is the person
7:01
Michael Graham: who is sick, right? And that is the fundamental problem we set out to solve. How do we empower individuals to understand what is happening in their body? How do you get them to start? thinking about how to prevent these things from happening? How do we get them to diagnose the things
7:20
Michael Graham: early while they're still curable? Right? And how do we reverse if they have gotten down the path? Can we actually reverse them? And that it was the genesis of Vio.
7:33
Unidentified speaker (speaker_1): Great. And I'm curious, you know, did you initially kind of come into um or initially were you thinking about the microbiome? You know, was that your initial target, I think, or did the bigger vision around personalize and preventive health, um, you know, did that kind of develop over time as
7:53
Unidentified speaker (speaker_1): you went through kind of what you wanted biome to look like?
7:57
Michael Graham: Yeah, I think it's really interesting, Susan. You brought it up. And I'm going to actually watch. walk you through the framework. As you know, this is my seventh venture. So having done the companies, whether it is a space exploration with Moon Express to my early days of the internet with InfoSpace and in between Intellius and
8:17
Michael Graham: Talentwise and on and on and on, I have done many different industries and I have developed a framework that I use every time I start a new company. a new venture. And anyone who's listening to it, any any any any fellow CEO, any fellow entrepreneur who's listening to it, and I'm gonna tell you the framework that I use,
8:37
Michael Graham: and I hope you use it for everything you do in your life. You ask yourself three questions why this? Why now? Why me? And why this is really simple. That says. God forbid, I am actually successful in solving this problem. Whatever that problem is,
8:57
Michael Graham: you assume you're going to be successful in solving this problem. Would it help a billion people live a better life? Would it help a hundred million people live a better life? And it's not because you are a philanthropic person. Yes, you are a philanthropic person, but more importantly, it is a not a flip just
9:17
Michael Graham: a philanthropic thing to do, it is a capitalist thing to do. And here is a reason anytime you can build any product, any service that can help a billion people live a better life, you can create a hundred billion dollar company. But you never wake up in the morning thinking, What should I do to create a hundred billion dollar company?
9:37
Michael Graham: Making money is simple. simply a byproduct of doing things that improve people's life. That's simple, right? It is the people who focus on solving a problem. It is people who focus on actually solving a problem that helps people live better, healthier, is the people who end up creating a
9:56
Michael Graham: long-term sustainable enterprise sustainable enterprise.
10:01
Unidentified speaker (speaker_1): Yeah.
10:02
Michael Graham: Now the second part of that thing, and then I'm going to apply this framework to Wyoming because most people think this is all conceptual. How do you actually apply? So I'm going to take this framework and then I'm going to apply it to Wyoming so you can see how I apply that thinking to a company that I started. The second part of the
10:21
Michael Graham: puzzle is why now? Ask yourself what changed in the last two to three years? More importantly, what do you expect to change in the next three to five years that will allow you to solve this problem at scale in three to five years? And this problem could not
10:41
Michael Graham: have been solved five years ago. And the reason is you never want to be using yesterday's technology to solve tomorrow's problem because then someone will come along by the time you're ready to scale, and they take the latest cutting-edge technology and you get disrupted even before you get a chance to scale.
10:59
Unidentified speaker (UNKNOWN): So
10:59
Michael Graham: you want to intercept. You want to intercept the technologies that are growing exponentially. You want to intercept them. So as the price performance curve is coming down, you're able to scale with them, even though you can do them today, but it is not. as price performance, and over time is going to get cheaper, better, faster, is where
11:19
Unidentified speaker (UNKNOWN): you're
11:19
Michael Graham: looking for. And
11:21
Michael Graham: that's really the key to really building a sustainable long-term business. The last part is probably the most important part, which is why me. And why me has
11:35
Michael Graham: first thing is the questions you ask are. the problems you solve. So if you are thinking the same way that everyone else in the industry is thinking, that means you are solving the same problem that everyone else is solving in the same way that everyone is solving. Maybe
11:55
Michael Graham: even if you're the smartest person in the world, you will be 10% better than them, but you'll never be 10 times better than them because to be 10 times better, you have to challenge the foundation of everything that the current experts have taken it for granted. You have to recreate, rechallenge, rethink everything.
12:15
Michael Graham: And that's where the disruption happens, Susan. So it is if one of the things that I learned is the questions you ask changes the problem. And I'll give you a complete completely different industry, and then I'm going to come back and talk about biome in a second here. So let's assume we all know there are 8 billion people on planet Earth.
12:35
Michael Graham: And by by 2050, some people believe that we may have 20 billion people on planet Earth. And if we're going to have 20 billion people, how would we solve world hunger? And you know, people who are experts will say, Oh, you have to grow more. food, you have to increase the yield of the crop, you have to reduce the
12:55
Michael Graham: wastage, amount of food that gets wasted in the transportation of the food. So you have to grow the food near where the populations are, and on and on. But nobody will ask the question, why do we eat food? Because when you ask the question why we eat food, you realize you need energy.
13:15
Michael Graham: and you need nutrition. How many different ways can you get energy? I mean, after all, we eat plants, right? Where do plants get energy? The nutrients, the nutrients from the fertilizer, nutrients from the soil, and radiation and carbon dioxide Side using photosynthesis.
13:35
Unidentified speaker (speaker_1): Yeah.
13:36
Michael Graham: Can we do the photosynthesis in our own body? I'm not saying how you know this is a problem that means by changing the question, I'm able to look for the solutions that were never available to you before. And that is a trick that people need to know that by changing questions, it changes the problem, it
13:56
Michael Graham: allows you to find solutions that were not obvious when you're talking about growing more food.
14:02
Unidentified speaker (UNKNOWN): Which
14:02
Unidentified speaker (speaker_1): I guess. oh, I want to go back to the the the nutrition and the
14:07
Unidentified speaker (UNKNOWN): food.
14:08
Unidentified speaker (speaker_1): Because I think, you know, you always talk about um, you know, there's not necessarily a universally healthy diet for
14:15
Unidentified speaker (UNKNOWN): everyone,
14:16
Unidentified speaker (speaker_1): right?
14:16
Unidentified speaker (UNKNOWN): Yes.
14:17
Unidentified speaker (speaker_1): And I think it's, you know, particular particularly interesting around um the microbiome and
14:23
Unidentified speaker (UNKNOWN): what
14:23
Unidentified speaker (speaker_1): everyone needs. So maybe go into that concept a little bit and
14:26
Unidentified speaker (UNKNOWN): why.
14:27
Unidentified speaker (speaker_1): different foods affect everyone differently, even though they could be very healthy foods,
14:31
Unidentified speaker (UNKNOWN): right?
14:31
Michael Graham: Absolutely, Susan. So again, applying this framework to wiome was really interesting. So we noticed that we asked ourselves: what if we can actually detect what changes in the human biology before people develop a disease? Would it help? 8
14:51
Michael Graham: billion people live a better life? A billion people live a better life. The answer is every one of us is going likely to suffer from these chronic diseases. So we can truly help the humanity if we can solve this problem. So answer the first question is helping a billion people live a better life? We of course can help
15:11
Michael Graham: everyone live a better life.
15:13
Unidentified speaker (UNKNOWN): And
15:13
Michael Graham: so we see said that it challenges. is check marked. Why now? And we said, look, to solve this problem, there are three things that have to happen. You have to be able to digitize the human body, you have to be able to process the massive amount of data that's coming out of it, and then you have to be able to use AI to be able to make sense of this massive amount of
15:33
Michael Graham: data. So 10 years ago, we saw, oh my God, the cost of uh sequencing cost. of digitization of human body is coming down. It used to be, you know, millions of dollars. It then came down to tens of thousands to thousand dollars. And we realize in the next three to five years, it is going to be down to $100.
15:53
Michael Graham: Ten years later, we are sitting here and I pay four dollars and seventy-three seventy three cents for his sequencing.
16:01
Unidentified speaker (speaker_1): Now
16:02
Michael Graham: the cost of cost of processing 10 years ago was $50 per sample. And I thought that was very high, but that you know the processors are getting you know the computers are getting faster, the storage is getting cheaper. And we were convinced that in three to five years that price will come down to ten dollars. Today
16:22
Michael Graham: we sit here at 90 cents. Right? And and that's coming down. And we all realized even 10 years ago that AI is going to get more and more powerful. So if we can start using AI at that time, we're going to have better and better AI as we grow. And that's exactly what happened. Now, the last part was the most
16:42
Michael Graham: interesting part. And one of the things in the framework, Susan, that I want to uh you know just tell people, because I think people go wrong here. Anytime when you're solving a problem, we have a tendency to focus on how we are going to do something. And that is the biggest limitations we put
17:01
Michael Graham: on solving problems. And never focus on how, focus on what problem needs to be solved. And I'll tell you why. If I say this problem I need to solve, I am not. the world's expert. If if I say how to do it, and if I don't know the answer, then I believe this problem
17:21
Michael Graham: cannot be solved. What I do is I say I don't know this industry. I don't need to know how. What I need to know is what problem do I want to solve, and then you can find the world's best who can help you solve. So never focus on how to. solve a problem, but focus on what problem
17:41
Michael Graham: needs to be solved. Now, good. Now, in why me was the most interesting for me. I noticed that everybody in the industry who was looking at this personalized nutrition or personalized medicine
17:56
Michael Graham: wanted to know our genes and our DNA. Every company was doing a DNA testing.
18:01
Unidentified speaker (speaker_1): Yeah.
18:02
Michael Graham: And as you remember, I mean, I don't need to know the names here, but you know all the companies I'm talking about. Everybody was doing DNA testing at that time. And I realized that does so my first question was Does DNA change when you become sick? And the answer is no. So if you do my DNA testing
18:22
Michael Graham: today and I gain 200 pounds, my DNA is still the same. Then I become dietary. diabetic. You can do my DNA test, it's still the same. Then I have a heart disease, and you can do my DNA test the same. Depression, anxiety, it doesn't matter. All the diseases, my DNA doesn't change. As a matter of fact, even after
18:42
Michael Graham: I die, you can exhume my body and take my DNA, just like we do DNA of dinosaurs. It's is still the same. Your DNA can can't even tell you you're dead or alive, let alone are you healthier or sicker. And that is the first thing I realized was oh my god, knowing your genes doesn't
19:01
Michael Graham: tell you anything because it doesn't even tell you you're sicker, healthier, dead, or alive. Then what is changing? And then I realized what changes is your gene expression or your RNA is always changing. So my first reaction was, why don't we just measure RNA?
19:20
Unidentified speaker (speaker_1): Yeah.
19:20
Michael Graham: And and but everybody who was an expert would have told you, oh, it can't be done. It is impossible to do. It is short-lived, blah, blah. But not knowing anything has a great advantage. Create We say, great, if that's a problem we need to solve, I'll go find someone who can help me solve that. problem. Now, the
19:40
Michael Graham: second part is what you're hinting at. It turns out 99% of all the genes in our body don't come from our mom and dad. They come from these microbiome that lives in our gut, in our mouth, all over us. 100 trillion microbes living inside us and on
20:00
Michael Graham: us that produce some. somewhere between 2 million to 20 million genes compared to 22,000 protein coding genes in the human DNA. That means most of who we are as humans is really these microbes with a sprinkle of our mom and dad's genes,
20:20
Michael Graham: right? Rest is all come from these microbes along around
20:24
Unidentified speaker (UNKNOWN): us.
20:24
Michael Graham: Now, what's interesting is just like DNA, companies doing DNA testing.
20:31
Unidentified speaker (speaker_1): Yeah.
20:32
Michael Graham: Every so first thing I did was, does this microbiome matter? In those days, there was no chat GPT, so you went to Dr. Google
20:40
Unidentified speaker (UNKNOWN): and
20:40
Michael Graham: you start saying Parkinson's and microbiome, Alzheimer's and microbiome, cancer and microbiome, a diabetes and a microbiome, and health disease, and my it turns out every single disease. was actually had association and causation with microbiome.
20:55
Unidentified speaker (UNKNOWN): And
20:55
Michael Graham: my oh my god, if microbiome is so important, then why is this problem not getting solved? Because there are so many companies who are doing microbiome testing. Why is this problem still stays? And then I went back to the same first principle: what is this microbiome companies doing? And it turned out that every microbiome.
21:15
Michael Graham: company is doing the DNA of your microbiome. They do something called metagenomics,
21:21
Unidentified speaker (UNKNOWN): which
21:22
Michael Graham: is what organisms are in your gut. And Susan, that's the same problem. If you simply know what are your genes or what organisms are in your gut, it doesn't tell you anything because the same organism can produce something good in one environment. and it can produce something bad in a different
21:41
Michael Graham: environment. Just like a human being, you take a person, put them in a good environment, good behavior, put them in the bad environment, bad behavior. And these organisms really behave the same way. They change their functions based on what else is happening around them. What are the things people are eating? What kind of stress
22:01
Michael Graham: their body is in. what kind of exercise the person is doing, what kind of sleep people are getting. Every one of these things are impacting how the microbiome actually behaves. They are exactly the same, but their functions change based on the environment. And this is how microbiome
22:21
Michael Graham: adapts Adapt to the environment that they live themselves in.
22:25
Unidentified speaker (UNKNOWN): Now,
22:26
Michael Graham: this is really interesting. So then my problem was really simple. Understand what microbes are producing, not who they are. That means do the RNA of microbiome, do the RNA of the human body. And if we can take everything and put them all together, then we will know
22:46
Michael Graham: everything that's happening in the body for each disease, and we'll be able to solve this problem.
22:51
Michael Graham: And that is essentially how what we set out to do. And then I was thought it was really simple. I went to Stanford, I went to MIT, I went to NASA, and I thought somebody had to have figured this out. And I went from university to university, went to Lawrence Livermore's Lawrence Burk Lawrence Berkeley, and then I was at Los Alamos
23:11
Michael Graham: National Lab, where there was a scientist who was working. on a biodefense project. And guess what? The problem they were trying to solve was very similar. They were trying to figure out what if there was a biological terror in our great country, how would we protect our citizens? And what they were able
23:31
Michael Graham: to do was they found the problem was very similar. They couldn't care less which organism is there, they wanted to know. what these organisms are doing inside the human body, how is it reacting to the immune system so they can create antidote for it?
23:48
Michael Graham: So they are building all these technologies, and this scientist is describing to me what he's working on. And I'm thinking this is exactly the problem trying to solve. We ended up hiring that person to become my chief science officer. I hired the head of IBM Watson Research to do all the AI for
24:08
Michael Graham: me. And then we started Vyome and we licensed the technology from Los Alamos National Lab. So we have the exclusive perpetual license to this technology. And then we started a company called Vyome. Now, Now, fast forward 10 years later, Susan, we have now done 1.5
24:27
Michael Graham: million tests. We have now collected over 10 quadrillion biological data points. We have the largest database on humanity ever assembled by a human. And the reason I qualify by a human is I don't know what Martians may or may not have done on humans yet. So I'm gonna going to say no other
24:47
Michael Graham: human humans have done it yet.
24:50
Michael Graham: So there we have it, right? So we have the largest database. And then interestingly, based on this data, I can now tell you. So every time you get a test from wine, it is called full-body intelligence. You give us a spit of your saliva,
25:10
Michael Graham: you give us a four drops of your finger fingerprint prick blood, and you give us a touch. of your stool, we analyze 100 million biomarkers.
25:21
Unidentified speaker (speaker_1): Wow.
25:21
Unidentified speaker (UNKNOWN): So
25:22
Michael Graham: every single gene expression in your blood, that means your mitochondria, your immune system, your oral microbial gene expression, your gut microbial gene expression, your gut lining, your gum lining, your immune system, everything in your body. We analyze everything. And then I say, Susan, based
25:42
Michael Graham: on this, this is your biological age, this is your cognitive health, this is your heart health, this is your gut health, this is your oral health, this is your mitochondrial health, this is your immune health. And if you want to be nerdy with me, I have all the nerdy information from you: your LPS production to your
26:02
Michael Graham: flagellus. flagellar assembly production, right? But what we do is I say, Susan, don't eat avocado right now because your uric acid production is very high. Here is the score for uric acid, and here is a science paper that tells you if you keep eating this, you're gonna develop Developing a gout. out.
26:22
Unidentified speaker (speaker_1): Okay, that's interesting. That's very interesting. Yeah,
26:25
Unidentified speaker (UNKNOWN): and then we
26:26
Michael Graham: say, Don't eat. broccoli right now, despite everyone think it is healthy. Your sulfide score is very high. Here's your sulfide score. Here's a science paper that tells you how it's causing inflammation in your body.
26:40
Unidentified speaker (UNKNOWN): Or don't eat
26:41
Michael Graham: spinach right now. Spinach everyone thinks is healthy, or almonds are healthy. We can tell you don't eat them because they're very high in oxalates. and your gut microbiome is not able to. And then we tell you in addition to the food, you should take 22 milligrams of lycopen every day, take 18 milligram of elderberry every day,
27:01
Michael Graham: take 89 milligram of amylase every day, and then walk you through every vitamin, every mineral, every herb, every digestive food enzyme, and every food extract, and then we custom formulate that supplement. formula only for you. There is no pre-made formula, there is no pre-made capsule. We make that formula
27:21
Michael Graham: only for you every month. And then we, based on your wearable data every month, based on your electronic medical records, based on your feedback, we change that every month as your body is changing. So we say, look, you have been working out a lot, let me change your formula. Or you're not sleeping well, let me change your formula. And then we also give you your personalized
27:41
Michael Graham: probiotic, prebiotic, postbiotic for your gut. We give you personalized oral losenges. We make the personalized toothpaste for morning and personalized toothpaste for evening. And we actually did double-blinded placebo control studies to show if you follow this for 90 days, if you are were
28:01
Michael Graham: pre-diabetic, your A1C. came down by 0.42. If you had IBS, which is 15% of all the population suffers from IBS, we showed 67% of the people became healthy compared to 9% on placebo. There is not a drug, by the way, that works that effectively. If you had anxiety or
28:21
Michael Graham: depression, 50% of the people became healthy compared to 28% people on placebo. And then we showed we developed another probiotic, symbiotic with a prebiotic and probiotic, and we showed a woman with osteopenia 85%
28:40
Michael Graham: improvement in bone loss. Think about that for a second. So if you are perimenopause, Menopause, menopause, you're losing bones. If you're taking GLP1, you're losing bones. So we build the product for actually for everyone so that they can prevent from the bone loss from happening. So every woman who's above 40, every woman who is in
29:00
Michael Graham: perimenopause, menopause, everyone who's taking GLP1, men or women, they're gonna lose the muscle mass, they're gonna lose the bones, bone loss, and they're gonna have digestive effects. So the people have constipation, nausea, we have our probiotics. probiotic that can help you with that. People develop bad breath. We have a oral disease and
29:20
Michael Graham: a toothpaste that helps you with that. People also lack nutrition, and our supplement fills in the all the nutritional gap when you're on GLP1. So we have a complete GLP1 companion. So as you take GLP1, GLP one, you can take these things so you don't have the side effect of GLP1 GLP one while getting on. all the benefits of
29:40
Michael Graham: GLP one.
29:41
Unidentified speaker (speaker_1): Do you see so most people that do the tests, do they typically then transition into your supplements and
29:50
Michael Graham: you know
29:50
Unidentified speaker (speaker_1): continue? I guess what percent continue to, you know, get retested and continue to adjust, which I assume over time, like their supplements probably adjust over
30:01
Unidentified speaker (UNKNOWN): time,
30:01
Unidentified speaker (speaker_1): right?
30:02
Unidentified speaker (UNKNOWN): As they kind
30:02
Unidentified speaker (speaker_1): of follow the process, right?
30:04
Unidentified speaker (UNKNOWN): Yes.
30:05
Michael Graham: Yeah. So uh we have up almost forty five percent of the people who do a test, they actually also take our supplement. And and people generally do a retest every six months. Some people take it every once
30:18
Unidentified speaker (UNKNOWN): a
30:18
Michael Graham: year, but we recommend four to six months. And as you do a retest, your food recommendations change, your supplements change, your biotics change, your you know all the things as your body is changing, it's constantly adapting to your body. And that's really interesting. Part is, but most importantly, Susan, based
30:37
Michael Graham: on all of this data that we have collected from one and a half million tests now, we are able to now diagnose very early diseases. Just two weeks ago, we launched a stage one pancreatic cancer test.
30:53
Unidentified speaker (speaker_1): Wow.
30:55
Michael Graham: This is the world's first stage one pancreatic cancer test that you can buy today. It detects stage one pancreatic cancer at 90% specificity, 86% sensitivity. Compared to companies like Grail, their stage one sensitivity is 13.7%. ours
31:15
Michael Graham: is 86%. We have
31:18
Michael Graham: stage one oral cancer test, stage one throat cancer test. I mean, these are the tests that people thought was not possible. I mean, this is how I lost my dad. Coming back full circle, we are able
31:31
Unidentified speaker (UNKNOWN): to
31:31
Michael Graham: detect stage one pancreatic cancer test, and our negative predictive value, Susan, is 99.9%. That means when we tell you you do not have a pancardia cancer, you do not have a pancardia cancer.
31:44
Unidentified speaker (speaker_1): Yeah. Now, are you working with any healthcare companies at all to maybe try and utilize this with them?
31:52
Michael Graham: So we are working with all of the healthcare providers, concierge doctors, longevity medicine doctors, doctor, functional medicine doctors. But we have had very little success in terms of going to the healthcare systems or insurance companies. Because the problem
32:11
Michael Graham: is, again, going back to our healthcare system, most insurance companies know that everyone changes their healthcare every two years. Every employer has have a new healthcare system every two years. Why would they want to detect something early? Because then they have to pay for it. They'd rather delay the detection so it becomes someone
32:31
Michael Graham: else's problem.
32:32
Unidentified speaker (speaker_1): Yeah.
32:33
Michael Graham: Right?
32:33
Unidentified speaker (speaker_1): Yeah, exactly. Yeah.
32:35
Unidentified speaker (UNKNOWN): So then
32:35
Unidentified speaker (speaker_1): they utilize the system more. Yeah.
32:38
Michael Graham: And that's the thing is so what we are trying to do is trying to get people who care about their own health to pay for themselves. And these we are trying to make these tests so cheap that everyone can afford them. right? And that's the key is we take our tests and we don't try to gouge people. For example, all three
32:58
Michael Graham: RNA tests, all of them, saliva, blood, stool, we retail them for $3.99 on our website. So you can go to VyM.com and buy them today. We don't try to charge you $1,000, even though we could, but we don't, because we want people to use this, right? And we try to do our best, even for our oral cancer,
33:18
Michael Graham: throat cancer, pancreatic cancer. And by the way, we should have the data on collin polyps within weeks. We just got the interim samples from scripts. Scripts is our partner for collin polyps. And if our expectation is that it will be 90% plus in terms of area under the curve, compared to exact science
33:38
Michael Graham: at 48%.
33:39
Michael Graham: And none of the people have been able to detect uh colon polyps. I the reason we are succeeding where others have failed, Susan, is RNA. RNA changes right at the onset of a disease. And companies like Graham, they're looking for cell-free DNA. So that means your tumor has to be big enough for it
33:59
Michael Graham: to shed for you to find it. And that's the reason you saw. that trial for grail they completely missed stage one and two because they weren't able to reduce them in stage three and four and that is a problem they are very good at telling you when you're about to die that you have a cancer. Yeah
34:19
Unidentified speaker (speaker_1): it doesn't help you much
34:21
Unidentified speaker (UNKNOWN): it doesn't help have too you
34:21
Michael Graham: much
34:22
Unidentified speaker (speaker_1): yeah so you know I guess a lot of consumers you know, they're I think they're good about uh, you know, maybe taking the test and you know, and then you tell them what to do. I guess, you know, then they want to see if it actually works. So you kind of talked about that
34:39
Unidentified speaker (UNKNOWN): a
34:39
Unidentified speaker (speaker_1): little bit.
34:40
Michael Graham: Yeah.
34:40
Unidentified speaker (speaker_1): Um, you know, and then I think you've made some recent acquisitions too. So maybe we could talk about talk about how those kind of flow together.
34:48
Michael Graham: Absolutely. So I think Susan, uh, I as just said first thing we wanted to make sure is that every single person who does our test they can be confident that it works. So we have published 20 peer-reviewed article, peer-reviewed journal articles. We have done six randomized control trials.
35:07
Michael Graham: Right? And then we acquired this company called Solaria Bio. And what's really interesting about them was they collect collected the microbiome from edible microbiome from vegetables, fruits, and fermented foods. And they collected 6,000 edible strains. And then they
35:28
Michael Graham: actually did all the analysis and they were able to find a consortium of three bacteria and a fungi. And they filed for IND.
35:39
Michael Graham: like a drug. Then they went through the toxicity trial, the animal model, phase one, phase two, and they showed 85% improvement that I was telling you for women ostepenia, 75%
35:54
Michael Graham: improvement in women with high fat or high BMI. Now this now, if they had our data, we could have made them subscribe substantially better because our data clearly shows what happens when people how people develop osteopenia. That means we can see that in their gut microbiome,
36:13
Michael Graham: we can see the osteoblast actually coming down, and osteoclast is going up. So that means we can see the degradation of bone happening. We can see that it's no longer rebuilding the bones. And we know what are the functions that are actually gone wrong. And then we can find the
36:33
Michael Graham: organisms and the strains that can actually fix those functions. So now think about how complementary it is. Our database tells you for every condition, pick a condition you want, joint pain, whether you have hair loss, whether you have acne, whether you have you know perimenopause. for each condition, we can say
36:53
Michael Graham: here are the functions that have changed, here are the strains that can actually fulfill these functions, and now we can have these probiotic and prebiotic together that can actually solve this problem. So we become an innovation engine for all of the companies, and every three,
37:13
Michael Graham: six, nine months, we can launch. these new products for very specific conditions based on our data.
37:20
Unidentified speaker (speaker_1): And so consumers really just need to take one test, and you guys can find all this out in one test.
37:26
Michael Graham: That's right.
37:27
Unidentified speaker (speaker_1): That's pretty amazing. And then they just keep take and then the next time they take a test, you see if it's the condition has improved at all.
37:34
Michael Graham: Exactly. And then we can show them exactly what changed and now what do they need to do to continue improving? Because as your body adapts, you can't keep doing the same thing. There is another thing that uh Susan is that there is no such thing as universal healthy food because even spinach or
37:53
Michael Graham: broccoli can harm people. In fact, in our data, we show 43% of the people are harmed by eating broccoli. Think about that.
38:03
Unidentified speaker (speaker_1): Why is that?
38:05
Michael Graham: And because they have very high sulfide production and broccoli is very high in sulfate, right?
38:11
Unidentified speaker (speaker_2): Yeah.
38:12
Unidentified speaker (UNKNOWN): Yeah.
38:13
Michael Graham: Same thing on the supplement side. When people are willy-nilly taking supplements, they're harming themselves. For example, people take NAD. What but they don't realize is that when you're taking NMN, NR, or an NAD. it also increases the progression of cancer.
38:30
Unidentified speaker (speaker_2): Yeah, so we had
38:31
Unidentified speaker (speaker_1): cancer.
38:32
Unidentified speaker (UNKNOWN): So if you have
38:33
Michael Graham: cancer, the last thing you want to do is to take NAD or NR or NMN. So endpoint is the same thing, it increases the oxidative stress. It you know, so
38:43
Michael Graham: acromancia is a great example. For There are companies who are selling acromancia acromansia as a probiotic. for saying it's going to help you improve your glucose control. And they don't tell you that acromansia is directly causative of multiple sclerosis. It's directly causing
39:03
Michael Graham: Parkinson's disease. Just a month ago, there was a journal article published that says acromensia in abundance of acromensia acromantia is related to Parkinson's disease.
39:14
Michael Graham: Right. So and point is so people take these supplements because they think it the neighbor told me that I told me to take this, or I'm listening to a TikTok influencer who is telling me to take alpha leopic acid.
39:28
Unidentified speaker (speaker_1): And they don't really, yeah, exactly. And that's what you guys are trying to help them understand what they actually need versus
39:34
Unidentified speaker (speaker_1): just take whatever what everyone one else. It's not a one-size-fits-all. one size fits all. Right.
39:37
Unidentified speaker (UNKNOWN): That's
39:38
Michael Graham: right. And the only rule here is anytime you hear everyone should take something, unless your name is everyone, just don't take it.
39:47
Unidentified speaker (speaker_1): Yeah, right. Um, okay, we have a couple minutes left here. I
39:51
Unidentified speaker (UNKNOWN): am
39:51
Unidentified speaker (speaker_1): curious to get your thoughts on, you know, we talked a lot about technology, RNA, The the microbiome, microbium, um, AI. Yeah. How do we bring this to the masses then? Which is kind of what you opened with, I guess, a little bit, right? So, how do we, you know, obviously a lot of healthy, you know, health net people are gonna,
40:11
Unidentified speaker (speaker_1): you know, latch onto this. How do we bring it to the masses to make everyone healthy?
40:16
Michael Graham: And and again, the way we do that is everything starts with N of one. And then we learn from that, then we build the thing called is segment. segmented. Oh, this person, these group of people need this, and this group of people need this. And then we moved to condition-based thing now. So think about it.
40:36
Michael Graham: Now you don't have to do my test. I can simply say, look, if you have a bone loss, I have a product you can just buy today. And you don't have to do any test anymore because we learned everything now. What we need to do. You can now
40:49
Unidentified speaker (UNKNOWN): buy
40:49
Michael Graham: these if you have constant. constipation. Here's a product for you. If you have a gum inflammation, here's a product for you. So this is how we can reach masses without, and you can now sell them on retail store, you can sell them as a CPG product because now, based on the data and AI we learned, we can now bring it to the masses. And the cost
41:09
Michael Graham: of the test are plummeting. So 10 ten years ago, when we launched the test, we charged.
41:15
Michael Graham: $995 for simply one test of one stool test. Today we charge $399 for three tests.
41:25
Unidentified speaker (speaker_1): Wow. Wow. So
41:26
Unidentified speaker (UNKNOWN): the
41:26
Unidentified speaker (speaker_1): cost has really come down a lot. Yeah.
41:28
Michael Graham: And and it's gonna continue going down as we are as our economy of scale is growing, as the cost of sequencing is plummeting, as a cost of AI. we are we will be able to make these tests available for 10, 20, 30 dollars.
41:45
Unidentified speaker (speaker_1): Yeah, everyday people. Yeah, exactly.
41:48
Unidentified speaker (speaker_1): Um okay, one last question, just kind of stepping back a little bit from biome and just looking at the longevity industry in general and more broadly, you know, obviously there's an enormous amount of excitement around longevity right now. Yeah. Um, it's really just kind of a, you know, a hot, hot area. Um, I
42:08
Unidentified speaker (speaker_1): guess if we fast forward five, 10 years, like what do you think, you know, consumers will actually be doing differently to live longer, healthier lives? And, you know, which of today's longevity trends do you think will prove to be truly meaningful?
42:21
Michael Graham: There's no doubt in my mind. There's that something that our mothers told us. before is really what you need for longevity. There are five things you need to stay healthier longer. Number one, nutrition. Until you have the right fuel in your body, nothing matters. So make sure the
42:41
Michael Graham: food you're eating is right for you, not right for someone else. That's number one. Number two, reduce the stress. Anytime you underfive are in the fight or flight response, when your body is under stress, evolutionary you're being chased by a tiger. So your digestive system shuts down, your immune system shuts down, your body is no longer able
43:01
Michael Graham: to process, and your cortisol in the body is changing your microbiome constantly. So reduce the stress in your body. That means you need to be able to find a way to either
43:14
Unidentified speaker (UNKNOWN): change.
43:15
Michael Graham: the environment you are in, whether it's your job, whether it is your home, or whether it is, or learn to actually change how you look at the problem, which is it is what it is, it will be what will be, right? That means you don't start you focus on actions, not on the outcome. Yes, and
43:35
Michael Graham: that's really changes the eastern philosophy of saying car car. karma is the only thing we can do as humans and you focus on karma and not outcomes. Right.
43:44
Unidentified speaker (UNKNOWN): The
43:45
Michael Graham: number three is exercise. You have to move your body. You have to move. So I do at least four or five miles a day walk. I also do three to four times a week. I am doing strength training. So I am doing the uh is uh weights three to four times a week. And especially as we are
44:04
Michael Graham: aging, and now obviously students know people can't see me, but I'm 67 years old now, right?
44:10
Unidentified speaker (speaker_1): I was gonna say because I know your biological age is really low, so let's just
44:14
Unidentified speaker (UNKNOWN): hear
44:14
Unidentified speaker (speaker_2): what it is.
44:15
Unidentified speaker (UNKNOWN): Yeah,
44:15
Michael Graham: yeah. So I'm I'm um chronologically 67. That means the earth has gone around the sun 67 times since I was born, but biologically, my biological age is now down to 330. Right.
44:30
Unidentified speaker (speaker_1): Wow, that's amazing, amazing.
44:33
Michael Graham: And and by the way, I didn't start my health journey until about 10 years ago. So think about in 10 years, I have improved substantially. If you go back and look at my pictures when I was in my 40s, I was obese. I I was sick, I was inflamed. I I in a and today. today every biomarker
44:53
Michael Graham: in my body is optimized for. In fact, I have a APOE4 variant that people think I'm gonna develop Alzheimer's, which is what high risk for Alzheimer's. Guess what? I just last week I did the test for P tau. It is below the level of the detection of the test. You can't even detect
45:12
Michael Graham: it.
45:14
Unidentified speaker (speaker_1): Wow. that's
45:15
Unidentified speaker (UNKNOWN): great. So it
45:16
Michael Graham: tells you it is working. So my point is
45:18
Unidentified speaker (UNKNOWN): and
45:19
Michael Graham: the number four is sleep. And the sleep is it's not the quantity of sleep, it is the quality of sleep. And most people somehow have been this myth about you have to take eight hours of sleep. You need one and a half hours to two hours of REM RAM sleep, and you need one hour to one and a half.
45:39
Michael Graham: hour of deep sleep. Because deep sleep is when your lymphatic system is moving all the toxins out, and the RAM is how you consolidate your memory. So I measure my sleep. I have my aura rig. I have my Apple Watch. I use my Whoop. I use my eight sleep mattress. So I am using everything to make sure I'm getting a good night's
45:59
Michael Graham: sleep.
46:00
Unidentified speaker (speaker_1): Okay.
46:00
Michael Graham: Number five purpose and communication. community. People who live a life of purpose tend to live eight to ten years longer than the people who have no purpose. People who have family and community that you uh that loves you and you love them. Really, the community in the blue zone, one thing they find in common is community. People are
46:20
Michael Graham: close to each other. So
46:22
Unidentified speaker (UNKNOWN): my last
46:23
Michael Graham: sentence, last will be find something that you're willing to. die for and then live for it. Find your purpose in life and live for your purpose.
46:32
Unidentified speaker (speaker_1): Yeah. I've heard a lot of those from a lot of people too. I think that that's there's a lot of truth to all five of those, definitely. Yeah. And I guess, you know, with social media and everything nowadays, and everyone just spending time on their phone, the the purpose thing may be a little bit harder, but everyone needs to find it, right?
46:51
Unidentified speaker (UNKNOWN): So
46:52
Unidentified speaker (speaker_1): great. Well, Naveen, this has been really, really helpful and very exciting and very fascinating. Thank you so much for taking the time to join us here. And
47:02
Michael Graham: of course. I
47:03
Unidentified speaker (UNKNOWN): uh Susan, it's been an
47:04
Michael Graham: absolute pleasure to be here. And you know, think about it. This at my age and having had unbelievable financial success coming from poverty to have having this unbelievable financial success, knowing that I don't have to work for a day for living. Uh, I
47:22
Unidentified speaker (UNKNOWN): am
47:22
Michael Graham: working 16 hour days, seven days a week, because this is a purpose for me to help humanity
47:27
Unidentified speaker (UNKNOWN): live
47:27
Michael Graham: healthier. And that's the kind of purpose. I'm not talking about simply doing nonprofit. I'm talking about building a company that can change the fellow humans' lives. So do something.
47:39
Michael Graham: that will change the trajectory of how humanity is going to live. Your fellow humans need you to go out and do something. Don't simply do things to make money, do things that can benefit everyone else.
47:52
Unidentified speaker (UNKNOWN): Well,
47:52
Unidentified speaker (speaker_1): thank you so much again. Take care,
47:54
Unidentified speaker (UNKNOWN): Sudan.
47:54
Unidentified speaker (speaker_1): Thank
47:54
Unidentified speaker (UNKNOWN): you
47:54
Unidentified speaker (speaker_1): for taking the time. Take care.
48:05
Unidentified speaker (UNKNOWN): As
48:05
Unidentified speaker (speaker_3): a reminder, this content is for informational purposes only and should not be taken as legal, business, financial, or investments advice. This content is not intended to promote any product or service of Can Accord Genuity. The opinions and views expressed in this program may not necessarily reflect the institutional views of Can Accord Genuity or its affiliates. This program should not be copied, distributed, published, or reproduced in whole
48:25
Unidentified speaker (speaker_3): or in part without the express written consent. of Can Occord Genuity. Certain information contained in this program constitutes forward-looking statements, and there is no guarantee that these results will be achieved. Can Accord Genuity has no obligation to provide updates or changes to the information in this program. Past performance does not guarantee future results, which may vary.
This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.
All insights